Calithera Biosciences IncCalithera Biosciences Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Other corporations in the scoring peer group for Calithera Biosciences Inc are displayed. Scroll down to the end of this webpage for potential risks for Calithera Biosciences Inc based on industry, location and size. This Disclosure rating covers seventeen United Nations SDGs including: 'No Poverty', 'Climate Action' and 'Life below Water'.

Calithera Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.6; made up of an environmental score of 4.0, social score of 4.0 and governance score of 5.7.

SDG Transparency Score for Calithera Biosciences Inc 
Low
0 - 3

4.6

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Calithera Biosciences Inc 
4.0

Environmental

4.0

Social

5.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
1156Vectus Biosystems Ltd
4.7
High
1156Zynerba Pharmaceuticals Inc
4.7
High
1199Calithera Biosciences Inc
4.6
High
1199Allergan Inc
4.6
High
1199AroCell AB (publ)
4.6
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Calithera Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Calithera Biosciences Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Calithera Biosciences Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Calithera Biosciences Inc offer flexible work?

LockedSign up for free to unlock

Does Calithera Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Calithera Biosciences Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Calithera Biosciences Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose water use targets?

LockedSign up for free to unlock

Does Calithera Biosciences Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Calithera Biosciences Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Calithera Biosciences Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Calithera Biosciences Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Calithera Biosciences Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Calithera Biosciences Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Calithera Biosciences Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose its waste policy?

LockedSign up for free to unlock

Does Calithera Biosciences Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose energy use targets?

LockedSign up for free to unlock

Does Calithera Biosciences Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Calithera Biosciences Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Calithera Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.

Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has completed Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and ATG-037, an orally-bioavailable small molecule inhibitor of CD73, as well as CB-668, an orally administered inhibitor of the enzyme IL4I1. The company has a license agreement with Mars, Inc. to develop and commercialize Symbioscience's portfolio of arginase inhibitors for use in human healthcare. It also has clinical trial collaboration with Pfizer to evaluate Pfizer's PARP inhibitor talazoparib and CDK4/6 inhibitor palbociclib, each in combination with telaglenasta. In addition, the company has a collaboration and license agreement with Incyte Corporation for the research, development, and commercialization of INCB001158, a small molecule arginase inhibitor for the treatment of hematology and oncology; and a license agreement with Antengene Corporation Ltd. for the development and commercialization of CB-708. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

Sorry!

Failed to process!